Achieved net sales of 6,128 million yen (up 38.5% YoY), operating profit of 2,079 million yen (up 90.2% YoY), and quarterly net income of 1,528 million yen (up 220.8% YoY).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4971","jir_company_name":"MEC Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4971-20260512-02.pdf","jir_short_summary":"Achieved net sales of 6,128 million yen (up 38.5% YoY), operating profit of 2,079 million yen (up 90.2% YoY), and quarterly net income of 1,528 million yen (up 220.8% YoY).","jir_summary":"### Performance Overview\nIn the first quarter of the 2026 December term, net sales reached 6,128 million yen (up 38.5% YoY), and operating profit was 2,079 million yen (up 90.2% YoY). Pharmaceutical sales increased to 5,997 million yen (up 41.5% YoY), and shipment volume rose to 12,978 tons (up 26.7% YoY). Sales of major products also increased YoY, with CZ series up 41.4%, SF up 37.1%, EXE up 26.8%, and V-Bond up 18.4%. FX effects contributed a positive impact of 286 million yen on net sales and 166 million yen on operating profit.\n\n### Outlook for the Future\nFull-year earnings guidance projects net sales of 24,500 million yen (up 17.0% YoY), operating profit of 7,600 million yen (up 32.2% YoY), and net income of 5,550 million yen (up 10.4% YoY). Mid- to long-term growth is expected driven by technological innovations related to IoT, AI, 5G\/6G, electric and autonomous vehicles, DX and GX advancements, and expansion of related markets. Particularly, increased demand for semiconductor package substrates and ultra-high-density products is expected to boost demand for 'CZ series' and 'Chemical Adhesion Enhancers.' While short-term fluctuations in the semiconductor market may affect key products, long-term demand growth is anticipated.","jir_financial_highlights":"Net Sales: 6,128 million yen (Up 38.5% YoY)\nOperating Profit: 2,079 million yen (Up 90.2% YoY)\nQuarterly (Current Period) Net Income: 1,528 million yen (Up 220.8% YoY)\nPharmaceutical Sales: 5,997 million yen (Up 41.5% YoY)\nShipment Volume: 12,978 tons (Up 26.7% YoY)\nROE: 4.9% (Unknown)","jir_category":"","jir_hashtags":"#MEC_Corporation, #FinancialResultsBriefing, #JapaneseStocks","jir_key_figures":"Net Sales: 6,128 million yen (up 38.5% YoY)\nOperating Profit: 2,079 million yen (up 90.2% YoY)\nQuarterly Net Income: 1,528 million yen (up 220.8% YoY)","jir_meta_title":"\u3010MEC\u30112026 Q1 Financial Results\uff5cNet Sales of 6,128 million yen (+38.5%) Operating Profit of 2,079 million yen (+90.2%)","jir_meta_description":"MEC Corporation's financial results for the first quarter of the 2026 December term. Net sales of 6,128 million yen (up 38.5% YoY) and operating profit of 2,079 million yen (up 90.2% YoY) showed significant growth. Also outlines mid- to long-term growth strategies.","jir_og_title":"\u3010MEC\u30112026 Q1 Financial Results\uff5cNet Sales of 6,128 million yen (+38.5%) Operating Profit of 2,079 million yen (+90.2%)","jir_og_description":"MEC Corporation's Q1 2026 financial results show net sales of 6,128 million yen and operating profit of 2,079 million yen, both increasing significantly YoY. Future growth prospects are also highlighted.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Consolidated Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024 Q1\\\",\\\"2025 Q1\\\",\\\"2026 Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (million yen)\\\",\\\"data\\\":[4423,4423,6128],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Consolidated Operating Profit Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024 Q1\\\",\\\"2025 Q1\\\",\\\"2026 Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit (million yen)\\\",\\\"data\\\":[1093,1093,2079],\\\"backgroundColor\\\":\\\"#59a14f\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Consolidated Product Segment Revenue (Q1 2026)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Pharmaceuticals\\\",\\\"Machinery\\\",\\\"Materials\\\",\\\"Others\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (million yen)\\\",\\\"data\\\":[5997,81,38,10],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\",\\\"#e15759\\\",\\\"#76b7b2\\\"]}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"region_segment_revenue\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Regional Segment Revenue Trends\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024 Q1\\\",\\\"2025 Q1\\\",\\\"2026 Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Japan\\\",\\\"data\\\":[1857,2191,2366],\\\"backgroundColor\\\":\\\"#4e79a7\\\"},{\\\"label\\\":\\\"Taiwan\\\",\\\"data\\\":[795,1006,1115],\\\"backgroundColor\\\":\\\"#f28e2b\\\"},{\\\"label\\\":\\\"China\\\",\\\"data\\\":[1265,1835,1894],\\\"backgroundColor\\\":\\\"#e15759\\\"},{\\\"label\\\":\\\"Europe\\\",\\\"data\\\":[259,269,379],\\\"backgroundColor\\\":\\\"#76b7b2\\\"},{\\\"label\\\":\\\"Thailand\\\",\\\"data\\\":[176,262,372],\\\"backgroundColor\\\":\\\"#59a14f\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"profit_margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin Trends\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2024 Q1\\\",\\\"2025 Q1\\\",\\\"2026 Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin (%)\\\",\\\"data\\\":[24.7,27.4,33.9],\\\"borderColor\\\":\\\"#4e79a7\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":40}}}}\"}]","ir_related_company":9582,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48175","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n